Should I apply for Asston Pharmaceuticals SME IPO?
A total of 1 recommendations were tracked for Asston Pharmaceuticals SME IPO. Out of 1 , 0 financial institutes/analysts have given rating for Subscribe, 1 for May Apply (50-50), 0 for Avoid and 0 hasn't given any rating. In terms of percentage 0% institutes has rated Asston Pharmaceuticals SME IPO for subscribe.
